Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy

Hepatology

Volumn 26, Issue 1, 1997, Pages 206-210

  Deutsch, Melanie ^a   Dourakis, Spyros ^a   Manesis, Emanuel K ^a   Gioustozi, Andreas ^a   Hess, George ^b   Horsch, Andrea ^b   Hadziyannis, Stephanos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHAN1 INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; THYROID ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CHILD; CHRONIC HEPATITIS; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DIAGNOSIS; ETIOLOGY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HYPOTHYROIDISM; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; VIRUS HEPATITIS;

EID: 0030927636     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260127     Document Type: Article

References (32)

1. Duclos-Vallee JC, Johanet C, Trinchet JC, Deny P, Laurent MF, Duron F, Valensi P, et al. High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis [Letter]. BMJ 1994;309: 846-847.
2. Quaranta JF, Tran A, Regnier D, Letestu R, Beusenel C, Fuzibet J-G, Thiers V, et al. High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies [Letter]. J Hepatol 1993; 18:136-138.
3. Pateron D, Hartmann DJ, Duclos-Vallee JC, Jouanolle H, Beaugrand M. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis [Letter]. J Hepatol 1992;16:244-245.
4. Tran A, Quaranta J-F, Benzaken S, Thiers S, Chau HT, Hastier P, Regnier D, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. HEPATOLOGY 1993;18:253-257.
5. Pawlotsky J-M, Yahia MB, Andre C, Voisin M-C, Intrator L, Roudot-Thoraval F, Deforges L, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. HEPATOLOGY 1994;19:841-848.
6. Huang M-J, Wu S-S, Liaw Y-F. Thyroid abnormalities in patients with chronic viral hepatitis [Letter]. HEPATOLOGY 1994;20:1651-1652.
7. McFarlane IG, Path MRC. Autoimmunity and hepatotropic viruses. Semin Liver Dis 1991;11:223-233.
8. Boadas J, Rodriguez-Espinosa J, Enriquez J, Miralles F, Martinez-Cerezo FJ, Gonzalez P, Madoz P, et al. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol 1995;22:611-615.
9. Ronnblom LE, Alm GV, Oberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991;115: 178-183.
10. Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL. Primary hypothyroidism associated with interferon therapy of breast cancer [Letter]. Lancet 1985;1:1166.
11. Burman P, Totterman TH, Oberg K, Karlsson FA. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab 1986;63:1086-1090.
12. Gisslinger H, Gilly B, Woloszczuk W, Mayr WR, Havelec L, Linkesch W, Weissel M. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 1992;90:363-367.
13. Fentiman IS, Balkwill FR, Thomas BS, Russell MJ, Todd I, Bottazzo GF. An autoimmune etiology for hypothyroidism following interferon therapy for breast cancer. Eur J Cancer Clin Oncol 1988;8:1299-1303.
14. Mayet W-J, Hess G, Gerken G, Rossol G, Voth R, Manns M, Meyer zum Buschenfelde K-H. Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. HEPATOLOGY 1989;10:24-28.
15. Watanabe U, Hasimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factor for development of thyroid disease during interferon-α therapy for chronic hepatitis C. Am J Gastroenterol 1994;89:399-403.
16. Boudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le Floch J-P, Lemmonier C, Benhamou J-P, et al. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol 1993;39:657-661.
17. Kodama T, Katabami S, Kamijo K, Katanuma A, Yamashita K, Azuma N, Tamaki T, et al. Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon. J Gastroenterol 1994;29:289-292.
18. Marcellin P, Pouteau M, Renard P, Grynblat J-M, Linhart NC, Bardet P, Bok B, et al. Sustained hypothyroidism induced by recombinant α interferon in patients with chronic hepatitis C. Gut 1992;33:855-856.
19. Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, Parker D, et al. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 1990;305:1419-1422.
20. Nolte FS, Thurmond C, Fried MW. Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA. J Clin Microbiol 1995;33:1775-1778.
21. Kuhns MC. Monitoring hepatitis B virus replication. J Hepatol 1990; 11:S90-S94.
22. Portmann L, Fitch FW, Havran W, Hamada N, Franklin WA, DeGroot LJ. Characterization of the thyroid microsomal antigen, and its relationship to thyroid peroxidase, using monoclonal antibodies. J Clin Invest 1988;81:1217-1224.
23. Klachko DM, Johnson ER. The liver and circulating thyroid hormones. J Clin Gastroenterol 1983;5:465-471.
24. Daly LE, Bourke GJ, McGilvray J. Interpretation and uses of medical statistics. Ed 4. Oxford: Blackwell Scientific Publications, 1991:398-415.
25. Norusis MJ. SPSS for Windows 95 (release 7.0). Chicago, IL: SPSS Inc., 1995.
26. Salabe-Lotz H, Salabe GB. Population survey of thyroid autoimmunity in Italy. Three year follow up. Thyroidology 1990;2:107-112.
27. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med 1990;112:840-849.
28. Berlowitz I, Ramot Y, Rosenberg T, Gilboa Y. Prevalence of thyroid disorders among the elderly in Israel. Isr J Med Sci 1990;26:496-498.
29. Berris B, Feinmann SV. Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig Dis Sci 1991; 36:1657-1660.
30. Marcellin P, Pouteau M, Benhamou J-P. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol 1995;22: 364-369.
31. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 1992;102:2155-2160.
32. Huang M-J, Liaw Y-F. Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 1995;10:344-350.